<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="table1" orientation="portrait" position="float">
 <label>Table 1.</label>
 <caption>
  <title>Passive immunization with convalescent plasma (CP) during SARS-CoV-1 and SARS-CoV-2 infection.</title>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" rowspan="1" colspan="1">Reference</th>
    <th valign="top" rowspan="1" colspan="1">Virus</th>
    <th valign="top" rowspan="1" colspan="1">Antibody source</th>
    <th valign="top" rowspan="1" colspan="1">Number of patients</th>
    <th valign="top" rowspan="1" colspan="1">Efficacy</th>
    <th valign="top" rowspan="1" colspan="1">Safety</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <break/>
     <xref rid="bib17" ref-type="bibr">Cheng et al., 2005</xref>
    </td>
    <td valign="top" rowspan="1" colspan="1">SARS-CoV-1</td>
    <td valign="top" rowspan="1" colspan="1">CP 
     <break/>160–640 ml 
     <break/>Seropositive titer range: 
     <break/>160–2,560
    </td>
    <td valign="top" rowspan="1" colspan="1">80 patients with SARS</td>
    <td valign="top" rowspan="1" colspan="1">Better outcome with plasma before than after day 14</td>
    <td valign="top" rowspan="1" colspan="1">No immediate adverse effects</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <break/>
     <xref rid="bib80" ref-type="bibr">Yeh et al., 2005</xref>
    </td>
    <td valign="top" rowspan="1" colspan="1">SARS-CoV-1</td>
    <td valign="top" rowspan="1" colspan="1">CP 
     <break/>500 ml 
     <break/>IF IgG titer 
     <break/>&gt;640
    </td>
    <td valign="top" rowspan="1" colspan="1">3 hospital workers with SARS</td>
    <td valign="top" rowspan="1" colspan="1">Drop within 24 hr in viral load from ~ 10
     <sup>5</sup> to &lt; 1 RNA copies/ml
    </td>
    <td valign="top" rowspan="1" colspan="1">No significant side effects</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <break/>
     <xref rid="bib62" ref-type="bibr">Soo et al., 2004</xref>
    </td>
    <td valign="top" rowspan="1" colspan="1">SARS-CoV-1</td>
    <td valign="top" rowspan="1" colspan="1">CP 
     <break/>Ab titers not measured
    </td>
    <td valign="top" rowspan="1" colspan="1">19 (plasma) vs. 21 (methylprednisolone) SARS patients</td>
    <td valign="top" rowspan="1" colspan="1">Faster release, lower mortality with plasma than comparator</td>
    <td valign="top" rowspan="1" colspan="1">No immediate adverse effects</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <break/>
     <xref rid="bib60" ref-type="bibr">Shen et al., 2020</xref>
    </td>
    <td valign="top" rowspan="1" colspan="1">SARS-CoV-2</td>
    <td valign="top" rowspan="1" colspan="1">CP 400 ml 
     <break/>Ab binding 
     <break/>&gt;1000 
     <break/>NAb &gt; 40
    </td>
    <td valign="top" rowspan="1" colspan="1">5 COVID-19 patients</td>
    <td valign="top" rowspan="1" colspan="1">Reduced viral load, clinical improvement Release of 3/5</td>
    <td valign="top" rowspan="1" colspan="1">None reported</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <break/>
     <xref rid="bib29" ref-type="bibr">Duan et al., 2020</xref>
    </td>
    <td valign="top" rowspan="1" colspan="1">SARS-CoV-2</td>
    <td valign="top" rowspan="1" colspan="1">CP 200 ml 
     <break/>NAb &gt; 640
    </td>
    <td valign="top" rowspan="1" colspan="1">10 COVID-19 patients</td>
    <td valign="top" rowspan="1" colspan="1">Virus undetectable in 7/10 
     <break/>Varying clinical, laboratory, radiological improvements
    </td>
    <td valign="top" rowspan="1" colspan="1">No adverse effects observed</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <break/>
     <xref rid="bib83" ref-type="bibr">Zhang et al., 2020</xref>
    </td>
    <td valign="top" rowspan="1" colspan="1">SARS-CoV-2</td>
    <td valign="top" rowspan="1" colspan="1">CP 200–2,400 ml 
     <break/>Ab not measured
    </td>
    <td valign="top" rowspan="1" colspan="1">4 COVID-19 patients</td>
    <td valign="top" rowspan="1" colspan="1">Negative PCR 
     <break/>Pulmonological improvements 
     <break/>Discharge of 3/4
    </td>
    <td valign="top" rowspan="1" colspan="1">No adverse effects observed</td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <break/>
     <xref rid="bib3" ref-type="bibr">Ahn et al., 2020</xref>
    </td>
    <td valign="top" rowspan="1" colspan="1">SARS-CoV-2</td>
    <td valign="top" rowspan="1" colspan="1">CP 2 × 250 ml 
     <break/>Binding IgG detected by ELISA
    </td>
    <td valign="top" rowspan="1" colspan="1">2 COVID-19 patients</td>
    <td valign="top" rowspan="1" colspan="1">Reduced sputum viral load Radiological and clinical improvements</td>
    <td valign="top" rowspan="1" colspan="1">No adverse effects observed</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
